Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 22 February, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Ajooni Biotech Ltd

About the Company - Ajooni Biotech Ltd

Ajooni Biotech Ltd. is a Public Limited Listed company incorporated on 17/02/2010 and has its registered office in the State of Punjab, India. Company’s Corporate Identification Number(CIN) is L85190PB2010PLC040162 and registration number is 040162. Currently company belongs to the Industry of Livestock - Hatcheries/Poultry. Company’s Total Operating Revenue is Rs. 74.04 Cr. and Equity Capital is Rs. 10.01 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Animal/Shrimp FeedD-118, Industrial Area, Phase - VII, Mohali Punjab 160055info@ajoonibiotech.com
http://www.ajoonibiotech.com
Management
NamePosition Held
Mr. Jasjot SinghManaging Director
Mr. Gursimran SinghWhole Time Director
Mr. Partek SinghDirector
Mr. Ramandeep SinghIndependent Director
Mr. Imteshwar SinghIndependent Director
Ms. Simmi ChabbraIndependent Woman Director

Ajooni Biotech Ltd. Share Price Update

Share PriceValue
Today₹6.90
Previous Day₹7.10

Basic Stock Data of Ajooni Biotech Ltd

Market Cap 60.4 Cr.
Current Price 6.90
High / Low7.70/3.05
Stock P/E33.9
Book Value 4.70
Dividend Yield0.00 %
ROCE6.01 %
ROE3.86 %
Face Value 2.00

Data Source: screener.in

Ajooni Biotech Ltd Quarterly Results

MonthSep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Sales12.1112.9116.1915.8518.3919.2920.5112.3110.2910.6341.2621.0019.48
Expenses11.8712.5415.8615.1317.4418.3220.0711.559.7010.1540.3220.3418.85
Operating Profit0.240.370.330.720.950.970.440.760.590.480.940.660.63
OPM %1.98%2.87%2.04%4.54%5.17%5.03%2.15%6.17%5.73%4.52%2.28%3.14%3.23%
Other Income0.000.000.010.010.010.010.010.010.000.020.260.070.29
Interest0.100.220.150.130.220.080.110.100.130.130.120.130.19
Depreciation0.060.220.140.190.290.340.290.250.250.260.240.210.21
Profit before tax0.08-0.070.050.410.450.560.050.420.210.110.840.390.52
Tax %25.00%14.29%0.00%24.39%22.22%19.64%220.00%23.81%19.05%0.00%35.71%-2.56%23.08%
Net Profit0.06-0.060.040.310.350.44-0.060.320.160.110.540.400.40
EPS in Rs0.01-0.010.000.030.040.04-0.010.030.020.010.060.050.05

Ajooni Biotech Ltd Quarterly Chart

Ajooni Biotech Ltd Profit & Loss

MonthMar 2011Mar 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales0.000.000.577.2113.2328.5342.2839.6540.0350.8274.0474.4892.37
Expenses0.000.000.567.0813.0027.8641.3538.9738.7949.1870.9671.7189.66
Operating Profit0.000.000.010.130.230.670.930.681.241.643.082.772.71
OPM %1.75%1.80%1.74%2.35%2.20%1.72%3.10%3.23%4.16%3.72%2.93%
Other Income0.000.000.000.010.000.050.220.340.060.020.030.290.64
Interest0.000.000.000.000.020.140.350.110.330.580.540.480.57
Depreciation0.000.000.000.030.070.190.310.440.490.581.111.000.92
Profit before tax0.000.000.010.110.140.390.490.470.480.501.461.581.86
Tax %0.00%27.27%28.57%28.21%20.41%14.89%29.17%26.00%28.08%28.48%
Net Profit0.000.000.010.070.100.280.390.410.350.371.051.121.45
EPS in Rs0.040.250.360.720.060.060.040.040.110.130.17
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Ajooni Biotech Ltd Profit & Loss Yearly Chart

Ajooni Biotech Ltd Growth

Compounded Sales Growth
10 Years:%
5 Years:12%
3 Years:23%
TTM:48%
Compounded Profit Growth
10 Years:%
5 Years:24%
3 Years:45%
TTM:69%
Stock Price CAGR
10 Years:%
5 Years:2%
3 Years:-8%
1 Year:9%
Return on Equity
10 Years:%
5 Years:4%
3 Years:4%
Last Year:4%

Ajooni Biotech Ltd Balance Sheet

MonthMar 2011Mar 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital0.010.010.240.240.240.335.866.168.4110.0110.0117.5217.52
Reserves0.000.000.120.190.290.645.096.017.495.656.3824.1523.20
Borrowings0.000.000.000.000.780.624.684.775.026.785.355.187.89
Other Liabilities0.000.000.141.191.1211.263.681.312.155.587.2711.889.35
Total Liabilities0.010.010.501.622.4312.8519.3118.2523.0728.0229.0158.7357.96
Fixed Assets0.000.000.010.200.301.141.041.022.075.166.216.296.08
CWIP0.000.000.000.000.000.000.000.000.000.000.000.260.75
Investments0.000.000.000.000.005.716.023.763.081.150.703.741.09
Other Assets0.010.010.491.422.136.0012.2513.4717.9221.7122.1048.4450.04
Total Assets0.010.010.501.622.4312.8519.3118.2523.0728.0229.0158.7357.96

Ajooni Biotech Ltd Reserves and Borrowings Chart

Ajooni Biotech Ltd Cash Flow

MonthMar 2011Mar 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 000-1-3-3-5-414-6
Cash from Investing Activity 00-0-0-2-010-3-2-16
Cash from Financing Activity 000158-132-222
Net Cash Flow000-005-5-10-00

Ajooni Biotech Ltd Financial Efficiency Indicators

MonthMar 2011Mar 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days57.6339.9933.3816.6324.6944.46115.2598.4768.23100.71
Inventory Days141.0222.3913.6263.2319.3750.7434.3945.6533.5338.81
Days Payable99.5565.9126.9078.669.0111.6120.1745.8238.7856.13
Cash Conversion Cycle99.11-3.5320.101.2035.0683.59129.4798.3062.9883.39
Working Capital Days96.054.569.38-29.4335.3990.03138.23112.0471.88110.66
ROCE %0.00%27.85%18.39%36.55%9.64%3.56%4.44%4.98%9.10%6.01%

Ajooni Biotech Ltd Financial Efficiency Indicators Chart

No valid data available for the Shareholding

Ajooni Biotech Ltd Shareholding Pattern Chart

No. of Ajooni Biotech Ltd Shareholders

This stock is not held by any mutual fund

Ajooni Biotech Ltd ROCE Trend

Ajooni Biotech Ltd EPS Trend

Ajooni Biotech Ltd Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
FaceValue2.0010.0010.0010.0010.00
Basic EPS (Rs.)1.941.050.370.410.67
Diluted EPS (Rs.)1.941.050.370.410.67
Cash EPS (Rs.)0.242.160.950.991.15
Book Value[Excl.RevalReserv]/Share (Rs.)4.7616.3715.6418.9119.76
Book Value[Incl.RevalReserv]/Share (Rs.)4.7616.3715.6418.9119.76
Revenue From Operations / Share (Rs.)8.5074.0051.0147.6364.53
PBDIT / Share (Rs.)0.343.111.661.551.43
PBIT / Share (Rs.)0.232.001.090.960.94
PBT / Share (Rs.)0.171.460.500.570.77
Net Profit / Share (Rs.)0.121.050.370.410.66
PBDIT Margin (%)4.104.203.263.242.21
PBIT Margin (%)2.752.702.132.011.46
PBT Margin (%)2.111.970.981.201.19
Net Profit Margin (%)1.501.410.730.861.03
Return on Networth / Equity (%)2.696.402.382.183.37
Return on Capital Employeed (%)4.7210.556.204.693.56
Return On Assets (%)1.913.611.331.502.25
Long Term Debt / Equity (X)0.040.150.120.080.01
Total Debt / Equity (X)0.120.320.430.310.05
Asset Turnover Ratio (%)1.702.602.001.942.11
Current Ratio (X)2.282.182.053.006.14
Quick Ratio (X)1.821.601.532.433.51
Inventory Turnover Ratio (X)10.2711.3510.018.3610.32
Interest Coverage Ratio (X)6.405.762.853.978.21
Interest Coverage Ratio (Post Tax) (X)3.352.941.642.064.84
Enterprise Value (Cr.)39.4872.6336.9611.2912.15
EV / Net Operating Revenue (X)0.520.980.720.280.30
EV / EBITDA (X)12.9023.3422.198.6813.81
MarketCap / Net Operating Revenue (X)0.460.900.590.150.30
Price / BV (X)0.834.111.940.401.00
Price / Net Operating Revenue (X)0.460.900.590.150.30
EarningsYield0.030.010.010.050.03

Ajooni Biotech Ltd Profitability Ratios (%)

Ajooni Biotech Ltd Liquidity Ratios

Ajooni Biotech Ltd Liquidity Ratios (%)

Ajooni Biotech Ltd Interest Coverage Ratios (%)

Ajooni Biotech Ltd Valuation Ratios

Fair Value of Ajooni Biotech Ltd Stock

Fair Value: ₹6.27

The stock is overvalued by 9.08% compared to the current price ₹6.9

*Investments are subject to market risks

Strength and Weakness of Ajooni Biotech Ltd Stock

StrengthWeakness
  1. The company has higher reserves (6.09 cr) compared to borrowings (3.16 cr), indicating strong financial stability.
  2. The company has shown consistent growth in sales (35.63 cr) and profit (0.58 cr) over the years.
  1. The stock has a low average ROCE of 10.04%, which may not be favorable.
  2. The stock has a high average Working Capital Days of 53.23, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 50.81, which may not be favorable.

Additional content added through batch update

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Ajooni Biotech Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE